Pulse oximeters’ inaccuracies in darker-skinned people require urgent action, AGs tell FDA
Twenty-five AGs called on the FDA to take urgent action on pulse oximeters' inaccuracies when used on people with darker skin.
More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin.
In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts, who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.
What's Your Reaction?
